David Coghill

Experts / David Coghill

Financial Markets Foundation Chair of Developmental Mental Health, The University of Melbourne

I am an academic child and adolescent psychiatrist based at the University of Melbourne departments of paediatrics and psychiatry. My main research focus is on neurodevelopmental disorders in children and youth. I spent much of my career in Scotland at the University of Dundee moving to Australia in 2016. Throughout my career I have kept a strong clinical interest with a particular focus on implementing evidence based care into routine clinical practice.

GPs could improve access to ADHD treatment. But we still need specialists to diagnose and start medication

Attention deficit-hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects 2.5–5% of people. Less than half of people with ADHD have been diagnosed and treated – though more and more people are presenting for help.

GPs could improve access to ADHD treatment. But we still need specialists to diagnose and start medication

Attention deficit-hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects 2.5–5% of people. Less than half of people with ADHD have been diagnosed and treated – though more and more people are presenting for help.

By Prof Adam Guastella, David Coghill

Clinical Articles

Neurology

David Coghill

Financial Markets Foundation Chair of Developmental Mental Health, The University of Melbourne

More from this expert

GPs could improve access to ADHD treatment. But we still need specialists to diagnose and start medication

Attention deficit-hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects 2.5–5% of people. Less than half of people with ADHD have been diagnosed and treated – though more and more people are presenting for help.

GPs could improve access to ADHD treatment. But we still need specialists to diagnose and start medication

Attention deficit-hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects 2.5–5% of people. Less than half of people with ADHD have been diagnosed and treated – though more and more people are presenting for help.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

David Coghill

Financial Markets Foundation Chair of Developmental Mental Health, The University of Melbourne

More from this expert

GPs could improve access to ADHD treatment. But we still need specialists to diagnose and start medication

Attention deficit-hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects 2.5–5% of people. Less than half of people with ADHD have been diagnosed and treated – though more and more people are presenting for help.

GPs could improve access to ADHD treatment. But we still need specialists to diagnose and start medication

Attention deficit-hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects 2.5–5% of people. Less than half of people with ADHD have been diagnosed and treated – though more and more people are presenting for help.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.